GBLP — Global Pharmatech Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $8.26m
- $6.66m
- $2.82m
Annual balance sheet for Global Pharmatech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2003 March 31st | 2004 March 31st | 2005 December 31st | 2006 December 31st | 2007 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10KSB | 10KSB | 10KSB | 10KSB | 10KSB |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 0 | 0 | 0.691 | 5.6 | 5.45 |
Net Total Accounts Receivable | |||||
Net Total Receivables | — | 0 | 2.44 | 2.04 | 1.76 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 0 | 0 | 5.28 | 9.19 | 8.08 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | — | — | 6.73 | 6.83 | 5.13 |
Net Intangible Assets | |||||
Total Assets | 0 | 0 | 12.2 | 16.1 | 13.3 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.135 | 0.053 | 1.42 | 1.42 | 4.19 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Liabilities | 0.135 | 0.053 | 4.93 | 5.04 | 5.29 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -0.135 | -0.053 | 7.25 | 11.1 | 8.04 |
Total Liabilities & Shareholders' Equity | 0 | 0 | 12.2 | 16.1 | 13.3 |
Total Common Shares Outstanding |